Author: Renubresearch01

United States Ultrasound Devices Market shall experience a CAGR of nearly 6.53%| Renub Research

Renub Research has recently released a report named “United States Ultrasound Device Market, Size, Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that incorporates market share insights. In addition, the report envelops research on competitors and regions and current advancements in the United States Ultrasound Devices Market. The United States Ultrasound Devices Market shall experience a CAGR of nearly 6.53%.Ultrasound is a non-invasive imaging technique that produces real-time images of the body’s internal structures and organs, allowing doctors to see the movement and function of these structures in real-time.

It is generally less expensive than other imaging modalities such as MRI or CT, making it more accessible to patients and often portable. It is ideal for use in emergencies or remote or rural areas. Ultrasound is safe because it does not use ionizing radiation, which can harm the body. Its ability to visualize various internal structures, including organs, blood vessels, and soft tissues, is versatile. Professionals can also use it for diagnostics and therapeutic procedures such as guided biopsies or fluid drainage.

There is an increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and respiratory disorders, which require regular imaging and monitoring using ultrasound technology. As per the American Hospital Association, approximately 133 million individuals in the United States, which is nearly half of the population, experience at least one chronic illness like hypertension, heart disease, and arthritis, and this number has increased by 15 million over the past decade. By 2030, this figure is expected to rise to 170 million.

The rising demand for minimally invasive diagnostics processes that utilize ultrasound technology has also helped grow the United States ultrasound devices market. These procedures are favored over traditional diagnostics methods as they cause no pain than other imaging techniques, have fewer side effects, and offer shorter recovery times. Moreover, advancements in ultrasound devices, such as improved image quality, portability, and ease of use, have made them an appealing option for medical practitioners and patients. The synergy of these factors has led to the expansion of the United States ultrasound devices market.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-ultrasound-devices-market-p.php

During the forecast period, the Portable/Handheld Ultrasound Systems segment shall exhibit substantial growth in the United States ultrasound device market

The current trend is to employ portable ultrasound devices in critical fields like cardiology, radiology, endocrinology, and gynecology, where they offer easy access to ultrasound imaging in limited spaces. These factors contribute to the significant growth of the United States ultrasound devices market. Moreover, the market growth is further accelerated by introducing novel and advanced technologies, the rising incidence of chronic illnesses, and the expanding range of applications of portable ultrasound devices.

Product Type – United States Ultrasound Device Market has been covered from 3 viewpoints

  1. Trolley/Cart-Based
  2. Compact/Handheld
  3. Point-of-Care (POC)

4D imaging segment shall maintain its dominant share in the United States ultrasound devices market

The 4D Imaging segment has achieved market dominance. It shall maintain a stable growth rate due to remote patient monitoring, increasing use of home healthcare, and a well-established healthcare infrastructure. In addition, government and private insurers are providing funding and investments for medical imaging services, recognizing the growing reliance on technology to improve healthcare services and quality of life. These factors also contribute to the growth of the 4D Imaging segment in the United States ultrasound devices market.

Technology Type – United States Ultrasound Device Market has been covered from 5 viewpoints

  1. 2D Imaging
  2. 3D Imaging
  3. 4D Imaging
  4. Doppler
  5. Others

Demand for ultrasound in pregnancy monitoring and gynecological diagnosis drives growth in the obstetrics/gynecology segment of the United States ultrasound device market

Obstetric ultrasound has become integral to women’s prenatal care, used to diagnose the reproductive system and surrounding organ ailments. The segment is expected to grow due to the increasing adoption of advanced diagnostics equipment in hospitals and gynecology centers, developed healthcare infrastructure, and the rising prevalence of gynecological issues.

The radiology/general imaging ultrasound category has maintained the highest share in the United States ultrasound devices due to several factors, including the growing number of radiological centers, a rise in the prevalence of chronic diseases, increased investments in advanced diagnostic imaging devices, and an increase in cancer incidence in the region.

Application – United States Ultrasound Device Market has been covered from 5 viewpoints

  1. Radiology/General Imaging
  2. Obstetrics/Gynecology
  3. Cardiology
  4. Vascular
  5. Others

Surgical centers is anticipated to experience a high growth rate in the future

Ultrasound use in surgical centers is growing due to various factors, including advancements in ultrasound technology that have made ultrasound-guided procedures more precise and efficient. Moreover, surgical centers find ultrasound devices appealing because of their cost-effectiveness and portability, which increases efficiency and reduce expenses. In addition, the growing demand for diagnostics and therapeutic interventions and the increasing incidence of chronic diseases also contribute to the expanding use of ultrasound in surgical centers.

End User – United States Ultrasound Device Market has been covered from 4 viewpoints

  1. Hospitals
  2. Surgical Centre
  3. Ambulatory Care Centre
  4. Other

Competitive Landscape

Key players such as Koninklijke Philips NV, Siemens AG, Hologic, Inc., Samsung Electronics Co. Ltd., and Canon Medical Systems Corporation are profiled in the United States ultrasound devices market report. These players focus on product development and implement various strategies such as mergers and acquisitions, license agreements, and partnerships to capture and maintain a significant market share.

Company Insights:

  • Overview
  • Recent Development & Strategies
  • Financial Insights

Company Covered:

  1. Koninklijke Philips NV
  2. Siemens AG
  3. Hologic, Inc.
  4. Samsung Electronics Co.Ltd
  5. Canon Medical Systems Corporation

Browse Related Report: 

Europe Ultrasound Device Market: https://www.renub.com/europe-ultrasound-devices-market-p.php

China Ultrasound Device Market: https://www.renub.com/china-ultrasound-devices-market-p.php

Hip Replacement Market: https://www.renub.com/hip-replacement-market-global-forecast-p.php

Orthopedic Prosthetic Market: https://www.renub.com/orthopaedic-prosthetics-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: http://www.renub.com

Cervical Cancer Screening Market is estimated to grow at a CAGR of 4.57% from 2022 to 2028 | Renub Research

According to Renub Research latest report, “Cervical Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” Global Cervical Cancer Screening Market will reach to US$ 34.72 Billion by 2028. Cervical cancer screening finds changes in the cervix cells that could lead to cancer. Screening includes cervical cytology (the Pap test or Pap smear), testing for human papillomavirus (HPV), or both. Most women should have cervical cancer screening regularly.

Cervical cancer screening is a simple, non-invasive procedure in a doctor’s office or clinic. Screening recommendations are tailored to individual risk factors, such as age, sexual history, and family history, making the screening process personalized and targeted. Cervical cancer screening can detect abnormalities in the cells of the cervix before they develop into cancer. Early detection allows for early intervention and treatment, increasing successful treatment chances. In addition, regular cervical cancer screening can significantly reduce the risk of developing cervical cancer. Cervical cancer screening is a cost-effective way to detect and prevent cervical cancer. According to this research report, Cervical Cancer Screening Market was US$ 26.52 Billion in 2022.

The increasing prevalence of cervical cancer worldwide will drive the demand for screening tests. In February 2022, the World Health Organization reported that cervical cancer ranked the fourth most frequently occurring cancer in women globally, with 604,000 new cases and 342,000 fatalities recorded by 2020.  Furthermore, the rising awareness about the importance of early detection of cervical cancer is adding to the demand for cervical cancer screening tests. In addition, the increasing adoption of minimally invasive techniques for cervical cancer screening, such as colposcopy and cone biopsy, is driving cervical cancer screening market growth as these techniques offer accuracy and reduces the need for invasive procedures.

Pap Smear Testing dominates the cervical cancer screening market as it is highly accurate

For several decades, Pap smear testing has been successfully detecting cervical cancer, making it a screening method with a long-standing history. It is also a cost-effective screening option, significant in countries with limited healthcare budgets. With its availability in healthcare settings, Pap smear testing is accessible to a large population. Furthermore, as a non-invasive screening method, it is less likely to cause discomfort and is suitable for women of all ages. Pap smear testing is highly accurate and can detect pre-cancerous cells before developing cancer. Training healthcare professionals in a clinic or doctor’s office can perform this screening method relatively quickly.

Government Policies and Educational Programs from various organizations contribute to the growing demand for cervical cancer screening in the United States

One of the primary reasons for death among women in the United States is cervical cancer, with approximately 14,100 women diagnosed with invasive cervical cancer, according to Cervical Cancer Statistics 2020. However, the accuracy and effectiveness of cervical cancer screening in the United States have improved with advanced screening technologies such as liquid-based cytology and HPV testing.

Favorable government policies also influence the overall market for cervical cancer tests in the United States. For instance, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides breast and cervical cancer screening, has helped drive market growth, per the updates given by the Centre for Disease Control and Prevention (CDC) in February 2022. In addition, the United States Congress has designated January as Cervical Health Awareness Month, which further underscores the importance of cervical cancer screening and contributes to market growth.

Healthcare organizations and advocacy groups, such as the National Cervical Cancer Coalition (NCCC) and its local chapters, have helped raise awareness about cervical cancer screening and early detection. For example, during Cervical Health Awareness Month in January, NCCC chapters organize events to increase community awareness.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-cervical-cancer-screening-market-and-patients-by-test-type-pap-smear-hpv-dna-via-forecast-1009-p.php

Competitive Landscape:

Companies in the cervical cancer screening market are striving to offer innovative products and services that are accurate, accessible, and affordable while also establishing strong distribution networks and effective marketing strategies to reach their target customers. Some major companies operating in the market are Abbott Laboratories, Becton, Siemens AG, Quest Diagnostics, Roche, Hologic Corporation, and Cardinal Health. 

Market Summary:

Type – Report covers Cervical Cancer Screening Market by type in 3 viewpoints (Pap Smear Tests Market, HPV DNA Tests Market, and VIA Tests Market).

Country – By country, the Cervical Cancer Screening Market breakup into 20 viewpoints (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway, Netherlands, United States, Canada, Japan, Korea, Singapore, Malaysia, India, China, Indonesia, Thailand, and Rest of world).

Key Players- All the major players in the report cervical cancer screening market have been covered from 3 Viewpoints (Overview, Initiatives and Recent Developments, and Sales) Abbott Laboratories, Becton, Siemens AG, Quest Diagnostics, Roche, Hologic Corporation, and Cardinal Health.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Hip Replacement Market, Size | Growth Forecast | 2028

Renub Research recently released a report titled “Hip Replacement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028″ providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the Hip Replacement Market. The Hip Replacement Industry shall expand at a CAGR of nearly 5.46%.from 2022 to 208.

Hip replacement is a medical intervention that involves the substitution of a damaged or diseased hip joint with a prosthetic joint composed of materials such as metal, plastics, or ceramic to alleviate discomfort, enhance mobility, and rehabilitate the normal function of the hip joint. Individuals may require hip replacement surgery due to various reasons, such as prevalent conditions like osteoarthritis, rheumatoid arthritis, avascular necrosis, bone tumours, and genetic bone disorders, as well as factors like hip joint injuries, previous surgeries, and congenital hip conditions. For instance, Globally, osteoarthritis affects 528 million people and results in 19 million years lived with disability, as reported by the World Health Organization (WHO).

As the population ages conditions that require hip replacement surgery increase. As per the “World Social Report 2023” by the United Nations, the population of people aged 65 and above has reached about 761 million, and it shall outdo 1.6 billion by 2050, more than double the present figure. In addition, the availability of better healthcare facilities, including hospitals and clinics with specialized orthopedic departments, has increased access to hip replacement surgeries for patients. Furthermore, the demand for minimally invasive procedures, which are less painful and have a shorter recovery time, has also contributed to the rise of the hip replacement market.

However, the hip replacement market is subject to limitations such as the high cost associated with the procedure, potential complications, implant failure risks, limited healthcare access in certain areas, and the likelihood of revision surgeries due to wear and tear or infection.

Total hip replacement is dominant in the hip replacement market due to its high success rates and effectiveness in treating various hip-related conditions

Total hip replacement is a popular option among patients and healthcare providers due to its high success rate of over 95% and effectiveness in treating various hip-related conditions, such as osteoarthritis, rheumatoid arthritis, avascular necrosis, hip fractures, and bone tumours. Many patients report significant improvements in pain relief, mobility, and overall quality of life following total hip replacement surgery, contributing to high patient satisfaction. Total hip replacement is a well-established procedure that has been performed for several decades, and experienced surgeons have refined their skills, leading to improved patient outcomes.

The significant rise of orthopedic clinics is due to the presence of proficient healthcare professionals and well-established infrastructure

The expansion of orthopaedic clinics in the hip replacement market is due to various factors, including the growing incidence of hip-related conditions, increasing awareness and desire for joint replacement surgeries, progressions in medical technology, advancements in healthcare infrastructure, and the provision of tailored orthopaedic services. Furthermore, orthopaedic clinics offer individualized treatment plans and specialized care to patients, leading to increased patient satisfaction and positive recommendations, which further contributes to the growth of orthopaedic clinics in the hip replacement market.

Request a free sample copy of the report: :https://www.renub.com/request-sample-page.php?gturl=hip-replacement-market-global-forecast-p.php

Asia-Pacific is predicted to grow the fastest in the Hip Replacement Market

The Asia-Pacific region’s growth in the hip replacement market can be due to several factors, such as the increasing geriatric population, rising awareness, and demand for joint replacement surgeries, improving healthcare infrastructure, and advancements in medical technology. Additionally, the region’s lower cost of living and lower labour costs has resulted in the establishment of many medical tourism destinations, attracting patients from around the world seeking cost-effective hip replacement surgeries. Furthermore, government initiatives to promote medical tourism and investments in healthcare infrastructure have also contributed to the rise of Asia-Pacific in the hip replacement market.

Competitive Landscape.

The hip replacement market is highly competitive and includes major players such as Smith & Nephew PLC, Johnson & Johnson, ConformisInc, Integra Lifesciences Corporation, MicroPort Scientific Corporation, Zimmer Biomet, Stryker, and Braun Melsungen AG. These companies continuously engage in product innovation, technological advancements, and mergers and acquisitions to gain a larger market share.

Market Summary:

  • Product – The Report covers Hip Replacement Market, by product in 3 viewpoints (total hip replacement, partial hip replacement, and revision and hip resurfacing).
  • End-User – Hip Replacement Market breakup in 3 viewpoints (hospitals and surgery centres, orthopaedic clinics, and others).
  • Region – Renub Research report covers the Hip Replacement Market by region in 5 viewpoints (North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa).
  • Key Players – All the major players have been covered from 4 Viewpoints (Overview, Strategy, Merger/Acquisition, and Financial Insight) Smith & Nephew PLC, Johnson & Johnson, ConformisInc, Integra Lifesciences Corporation, MicroPort Scientific Corporation, Zimmer Biomet, Stryker, and Braun Melsungen AG.

Related Reports

Hair Transplant Market, Size, Forecast 2023-2028

China Ultrasound Device Market, Size, Forecast 2023-2027

Bionic Devices Market, Global Forecast 2023-2027

Orthopedic Implants Market, Global Forecast 2023-2028

United States Ultrasound Device Market, Size, Forecast 2023-2027

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://linkedin.com/company/renub-research

Web: www.renub.com

Bionic Devices Market will experience a CAGR growth rate of 9.9% from 2022 to 2028 | Renub Research

Global Bionic Devices Market value will be around US$ 8.68 Billion by 2027. Bionics can transform the lives of individuals with disabilities or medical conditions and enhance the lives of those without impairments. Furthermore, the development of brain-controlled prosthetic limbs allows the movement of prosthetic limbs as if natural via implanted electrodes in the brain that can detect motor cortex signals.

Bionic devices offer sensory feedback by implanting electrodes in nerves, and exoskeletons powered by motors assist mobility. Also, 3D printing customizes prosthetic limbs and artificial organs to replace damaged organs. Moreover, advanced robotics technology allows for more precise surgical procedures. As per Renub Research report “Bionic Devices Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” Worldwide Bionic Devices Industry was USD 5.41 Billion in 2022.

Cochlear Implants’ High Success Rate made them famous for Hearing Loss Treatment

The high success rate of cochlear implants has fostered trust in the technology and its adoption, with individuals experiencing significant improvements in their hearing and communication abilities. Medical professionals and patients have grown familiar with using cochlear implants over the several decades by contributing to their popularity. Unlike prosthetic limbs, they are less invasive and can treat a wide range of hearing loss, including mild to profound, in individuals of all ages. In addition, technological advancements have made cochlear implants more compact, practical, and user-friendly, further bolstering their acceptance and use.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=bionic-devices-market-p.php

Increasing Functionality and Improved Design have led to the Flourishing of Wearable Bionics

Wearable bionics offer greater functionality, making them attractive to those seeking greater independence and quality of life. Advances in design have made them more comfortable, reducing the stigma associated with wearing bionic devices. They are now more affordable and accessible, and the growing awareness of bionics as a legitimate form of treatment has contributed to their popularity. In addition, wearable bionics can offer lifestyle benefits such as improved mobility and increased independence.

Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=bionic-devices-market-p.php

Electronic Technology Mimics Natural Human Body Parts, making it ideal for Bionic Devices

Electronic technology governs bionic devices due to its versatility, precision, and adaptability. It can mimic natural human body parts, be programmed precisely, and adapt to changing needs while being widely available and cost-effective. Integration with other fields, such as robotics, artificial intelligence, and 3D printing, has also enhanced bionic device capabilities.

The Demand for Bionic Clinics is on the rise due to Technological Advancements 

The rising need for bionic devices as a treatment option, thanks to technological advances making them more accessible, effective, and affordable, propels the demand for bionic clinics. In addition, integration with robotics and artificial intelligence has opened up new possibilities, while success stories have raised awareness. Finally, the aging population and prevalence of chronic conditions have created a growing need for innovative solutions to improve quality of life and independence.

North America has Hegemony in the Bionic Devices Market

The prevalence of chronic conditions and disabilities among the aging population in North America has resulted in a large market for bionic devices. A report published by Statistics Canada in October 2021 revealed that 60% of Canadians between 19 and 79 had hearing loss, tinnitus, or both conditions as measured by audiometric testing. Men were more susceptible to hearing loss and tinnitus than women. The region’s strong innovation culture and high awareness and acceptance of bionic technology have also contributed to its dominant position in the field. Finally, government funding for medical research and innovation has also played a significant role in driving the growth of the bionics industry in North America.

Recent Developments

  • In July 2022, Unlimited Tomorrow, a startup focused on prosthetics, released its latest bionic arm, called TrueLimb, featuring six adaptive grips that conform to objects the wearer interacts with and independent finger joints and subtle vibrations.
  • In February 2022, The Cysoni bionic launched a device for respiratory sinus arrhythmia by Ceryx Medical. The device replicates RSA by using a respiratory function to trigger heartbeats.

In conclusion, the bionics market’s future looks promising as technology advances. Bionic devices will continue to evolve and become more sophisticated, leading to better outcomes for patients with disabilities or medical conditions. Additionally, there will likely be more integration between bionics and other fields, such as robotics, artificial intelligence, and nanotechnology, creating new possibilities for treatment and rehabilitation.

Browse Related Report:

Bionic Devices Market: https://www.renub.com/bionic-devices-market-p.php

Orthopedic Implants Market: https://www.renub.com/orthopaedic-implants-market-p.php

Hip Replacement Market: https://www.renub.com/hip-replacement-market-global-forecast-p.php

Orthopedic Prosthetic Market: https://www.renub.com/orthopaedic-prosthetics-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email : info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Breast Cancer Screening Market, Size | Growth Forecast | 2028

Renub Research has recently released a report titled “Breast Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that includes market share insights. The report also includes competitor and regional research and contemporary advancements in the breast cancer screening market. The breast Cancer Screening Industry shall grow with a CAGR of nearly 5.26% from 2022 to 2028. Breast cancer screening involves a series of examinations and tests to identify breast cancer early before any visible symptoms manifest. Timely detection is critical as it increases the likelihood of successful treatment and survival. Mammography, clinical breast exam, breast self-exam, and magnetic resonance imaging (MRI) are some breast cancer screening techniques available in the breast cancer screening market. 

According to BreastCancer.Org, breast cancer accounts for about 30% of all new cancer cases in women annually in the United States. However, it is essential to acknowledge that these screening tests are not infallible and can sometimes miss cancer or reveal non-cancerous abnormalities. Additionally, screening tests may result in more testing and procedures, such as biopsies, which can cause emotional distress and physical discomfort. As such, healthcare providers’ consultation before breast cancer screening considers individual risk factors and preferences. 

As the population ages, demand for breast cancer screening services has increased due to the higher risk of developing breast cancer. Public awareness of the significance of early detection has also led to more women seeking screening services, adding to the rise in the breast cancer screening market. According to BreastCancer.Org, in 2022, over 3.8 million women in the US have a history of breast cancer, and approximately 15% of women who have breast cancer have a family member with the disease. 

In addition, advances in imaging technology, particularly digital mammography, have made screening more effective and accurate, further driving demand for screening services in the breast cancer screening market. In August 2022, the US FDA approved Enhertu, an IV fusion treatment for patients with the newly identified HER2-low breast cancer subtype that is either metastatic or unresectable, marking the first treatment specifically approved for patients with this subtype of HER2-negative breast cancer.

Growing Demand for Breast Cancer Screening Services in China Driven by Government Programs and Healthcare Industry Expansion

China’s enormous population of over 1.4 billion provides a significant market for breast cancer screening services, as breast cancer rates have been steadily increasing in recent years. The Chinese government has implemented programs to improve cancer screening and treatment, including breast cancer, which has increased the accessibility and affordability of screening services. In addition, the healthcare industry in China is expanding rapidly, leading to increased demand for medical services, including breast cancer screening. 

Indian Government Programs and Technological Advancements are driving the growth in the mammography Breast Cancer Screening Market

The implementation of various programs by the Indian government to improve cancer screening and treatment, specifically for breast cancer, has resulted in increased accessibility and affordability of screening services, including mammography. Moreover, the rapidly expanding healthcare industry in India has led to increased availability of medical services, including breast cancer screening. Furthermore, technological advancements such as digital mammography have increased the demand for mammography services in India by making breast cancer screening more accurate and effective.

United States MRI Breast Cancer Screening Market is growing because of the robust research and development culture and insurance coverage

Breast cancer is highly prevalent among women in the United States, resulting in a surge in demand for breast cancer screening services, including MRI propelling the rise of the breast cancer screening market. The cost of breast cancer screening, including MRI, is often covered by health insurance plans in the US, enhancing its accessibility and affordability for women. Additionally, the US has a robust research and development culture, resulting in the development of advanced breast cancer screening methods, such as MRI. As a result, the MRI breast cancer screening market has gained significant traction in the US.

 Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=breast-cancer-screening-mammography-mri-and-ultrasound-market-and-forecast-worldwide-63-p.php

 

Rapidly expanding healthcare industry and private sector investments support Brazil’s Breast Cancer Screening Market

Breast cancer is a significant public health concern in Brazil, leading to increased demand for screening services such as ultrasound in the Brazil breast cancer screening market. The Brazilian government has implemented programs to improve cancer prevention and treatment, making ultrasound more accessible and affordable. In addition, Brazil’s rapidly expanding healthcare industry and advances in ultrasound technology have made breast cancer screening more accurate than other screening methods, increasing demand for them in the breast cancer screening market. Private sector investments have also contributed to the growth of ultrasound breast cancer screening in Brazil.

Competitive Landscape.

AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc compete in the breast cancer screening market. 

Market Summary:

  • Breast Cancer Screening– The Report covers Global Breast Cancer Screening Market by breast cancer screening in 24 viewpoints (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAW, Saudi Arabia, and ROW).
  • Mammography Screening– The categorization of the global breast cancer market into 24 viewpoints based on mammography screening, including (the United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, the Netherlands, New Zealand, Australia, the United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW).
  • MRI Screening– Renub Research report covers the Global Breast Cancer Screening Market by MRI Screeningin 24 viewpoints (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAW, Saudi Arabia, and ROW).
  • Ultrasound Screening- By Ultrasound Screening, the Global Breast Cancer Screening Market is broken up into 24 viewpoints (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAW, Saudi Arabia, and ROW). 
  • Key Players– All the major players have been covered from 4 Viewpoints (Overview, Strategy, Merger/Acquisition, and Financial Insight);AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc.

Related Reports

Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028

Cervical Cancer Screening Market, Size, Global Forecast 2023-2028

Breast Implant Market, Size, Global Forecast 2023-2027

Non-Small Cell Lung Cancer (NSCLC) Market will reach US$ 25.71 Billion in 2027

Intratumoral Cancer Therapy Market, Size, Global Forecast 2022-2027

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Alzheimer’s Drug Market to Reach US$ 7.48 Billion by 2027: Opportunities and Growth Forecast | Renub Research

Renub Research has recently released a report named “Alzheimer’s Drugs Market, Global Forecast 2023-2027, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis” providing a detailed industry analysis that consists of market share insights. In addition, the report covers research on competitors and areas and current advancements in the Alzheimer’s Drug Market. The Alzheimer’s Drug Market shall expand at a CAGR of nearly 7.71%.Alzheimer’s is a degenerative neurological disorder causing cognitive decline, memory loss, and behavioural changes, accounting for 60-80% of dementia cases. Its exact causes are unknown but may involve genetic, environmental, and lifestyle factors, leading to brain cell damage, shrinking of brain tissue, and protein build-up. While no cure exists, treatments can improve quality of life and delay symptom onset with early detection and care.

Report Details:

Report FeaturesDetails
Base Year2022
Historical Period2018 – 2022
Forecast Period2023 – 2027
MarketUS$ Billion
Segment CoveredDrug Class, End-User, and Region
Region CoveredNorth America, Europe, Asia Pacific and Rest of World
Companies CoveredSanofi SA, F. Hoffman-La Roche Ltd., Pfizer Inc., Abbott Laboratories, Bayer, Merck & Co., BoehringerIngelheim GmbH, GlaxoSmithKline Plc., Novartis, Eli Lilly and Company, and Teva Pharmaceuticals
Customization Scope20% Free Customization
Post-Sale Analyst Support1 Year (52 Weeks)
Delivery FormatPDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

Dementiastatistics.org estimates that approximately 55.2 million individuals worldwide are affected by dementia, with the majority being individuals over 60.The rising incidence of Alzheimer’s disease, particularly among the aging population, has led to a higher demand for Alzheimer’s drugs as the global population ages. In addition, the high unmet medical needs for more effective treatments, advancements in research and development of new medications and treatment options, and government initiatives and funding for research have all contributed to the growth of the Alzheimer’s drug market. However, Alzheimer’s disease is poorly understood, which makes it challenging to develop effective drugs targeting its underlying mechanisms. In addition, high clinical trial failure rates and strict regulatory processes limit drug approval, while the expenses of medicines and limited insurance coverage limit access for some patients.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=alzheimer-s-pipeline-drugs-review-alzheimer-s-disease-drug-market-and-forecast-global-analysis-131-p.php

Alzheimer’s drug market for Donepezil drug shall grow further during the forecast period

Donepezil is an acetylcholinesterase inhibitor utilized in the treatment of Alzheimer’s disease, and the increasing prevalence of the disease, the aging population, and the high unmet medical needs primarily drive its growth in the Alzheimer’s drug market. The drug is one of the most commonly prescribed medications for Alzheimer’s disease and has demonstrated significant benefits in managing cognitive symptoms in patients. In addition, ongoing research, and development activities to improve the effectiveness of Donepezil and expand its applications in treating other neurological disorders are also contributing to its market growth.

Product – Alzheimer’s Drug Market breakup from 5 viewpoints

1.    Donepezil

2.    Galantamine

3.    Rivastigmine

4.    Memantine

5.    Others

Dominance of the hospital segment in the market can be due to the increasing hospitalization rates of older individuals and patients with Alzheimer’s disease

The increasing prevalence of Alzheimer’s disease among the aging population has led to more patients requiring hospitalization and specialized care. Additionally, hospitals have advanced medical facilities that can provide more effective and comprehensive treatment for Alzheimer’s patients. Moreover, hospital-based treatment approaches for Alzheimer’s are becoming more widely adopted, as hospitals can offer various services such as diagnostics, medication management, and rehabilitation. Lastly, supportive government initiatives aimed at improving hospital infrastructure and providing better healthcare services for the older and patients with Alzheimer’s disease have also contributed to the dominance of the hospital segment in the Alzheimer’s drug market.

End User – Alzheimer’s Drug Market breakup from 4 viewpoints

1.    Hospitals

2.    Clinics

3.    Nursing homes

4.    Homecare Centres

North America shall have the largest market share in the Alzheimer’s drug market

North America’s leading position in the Alzheimer’s drug market can be due to its large aging population, which increases the risk of developing the disease. According to the American Association, over 6 million Americans of all ages have Alzheimer’s, with a gauge of 6.7 million Americans age 65 and older living with the disease in 2023. Of those, 73% are 75 or older, and around 1 in 9 people 65 and older (10.7%) have Alzheimer’s.

North America’s dominance in the Alzheimer’s drug market is due to several reasons, such as its well-developed healthcare infrastructure, advanced medical facilities, skilled workforce, and high level of awareness and education about Alzheimer’s disease. Additionally, the region has an intense research and development base for Alzheimer’s drugs, with many pharmaceutical companies and academic institutions conducting research in this field. Supportive government initiatives and funding for Alzheimer’s research and treatment have also contributed to North America’s leadership in the Alzheimer’s drug market.

Region – Alzheimer’s Drug Market breakup from 4 Regions

1.    North America

2.    Europe

3.    Asia-Pacific

4.    Rest of the World

Competitive Landscape

All the key players in the Alzheimer’s drug market businesses invest in research and development activities and introduce new products to expand their share in the Alzheimer’s drug markets.

All key players have been covered from 3 viewpoints:

1.    Overview

2.    Strategy

3.    Financial Insight

Company Analysis:

1.    Sanofi SA

2.    F. Hoffmann-La Roche Ltd. 

3.    Pfizer, Inc.

4.    Abbott Laboratories

5.    Bayer

6.    Merck & Co.

7.    BoehringerIngelheim GmbH

8.    GlaxoSmithKline Plc.

9.    Novartis

10.    Eli Lilly and Company

11.    Teva Pharmaceuticals

Browse Related Report:

United States Generic Drugs Market: https://www.renub.com/united-states-generic-drugs-market-p.php

Coronary Artery Disease Market: https://www.renub.com/coronary-artery-disease-market-p.php

Cancer Pain Management Market: https://www.renub.com/cancer-pain-management-market-p.php

Hormone Replacement Therapy Market: https://www.renub.com/hormone-replacement-therapy-market-p.php

Diabetes Drug Market: https://www.renub.com/diabetes-drug-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Drip Irrigation Market, Size | Growth Forecast | 2028

Renub Research has recently published a report titled “Drip Irrigation Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the global drip irrigation market. The Global Drip Irrigation Industry shall experience a CAGR of nearly 9.89% from 2022 to 2028.

Drip irrigation, which delivers water directly to plant roots through a network of tubes, is widely used in agriculture, horticulture, landscaping, and gardening due to its ability to minimize water loss from evaporation and runoff. This targeted water delivery system results in better plant growth, higher crop yield, and improved crop quality. Furthermore, drip irrigation is more efficient, requires less maintenance and management than traditional irrigation methods, and reduces weed growth and soil erosion. It is also flexible and scalable, making it suitable for various landscape and crop types.

Drip or trickle irrigation involves supplying water to the soil at low rates through small plastic pipes equipped with emitters or drippers. Drip irrigation is more efficient than traditional irrigation methods, such as sprinkler irrigation, because it supplies water directly to the root zone, reducing water evaporation losses and making it popular in areas with limited water resources. As a result, governments worldwide are promoting water-efficient irrigation technologies, including drip irrigation, to tackle water scarcity issues. In addition, educational program implementation enhances farmers’ knowledge of modern farming techniques and increases the adoption of micro-irrigation systems. 

Though the determent of some growers in emerging economies by the high initial installation cost of micro-irrigation systems, market players are taking steps such as expanding their product portfolios, going global, and collaborating with governments to overcome this challenge and drive growth in the drip irrigation market.

Continuous technological advancements in drip irrigation systems and the high demand for staple food crops are driving the growth of field crops in the drip irrigation market

The supremacy of field crops in the drip irrigation market can be due to field crops being stapled food crops in high demand globally, creating a significant need for drip irrigation systems. Additionally, drip irrigation provides efficient water use for field crops, making it an attractive option for farmers looking to maximize yields while minimizing water usage. Furthermore, improved crop quality is also a benefit of drip irrigation, achieved through precise control over water and nutrient delivery. Finally, continuous technological advancements in drip irrigation systems drive their adoption in the field crop segment, making the designs more efficient, effective, and user-friendly.

Drip tubes’ growth in the drip irrigation market is because of their water efficiency and customization to meet crop and soil needs

Drip tubes enable clear water and nutrient delivery to plant roots, reducing water loss through evaporation and runoff and thus increasing water efficiency compared to other irrigation methods. Their customization options regarding diameter, length, and flow rates also provide tailored solutions to meet crop and soil requirements, enhancing water use efficiency and crop yields. Moreover, drip tubes are highly durable and resistant to outdoor factors like UV rays and temperature fluctuations, ensuring reliable and long-lasting performance. Lastly, constant advancements in drip tube design, including clog-resistant emitters and self-cleaning mechanisms, are making them more efficient, effective, and user-friendly, driving their adoption in the drip irrigation market.

Agricultural irrigation dominates the drip irrigation market due to high demand and the need for water-efficient crop irrigation, leading to improved crop quality and higher yields

Agriculture is a critical sector in many countries, and farmers are increasingly adopting drip irrigation to address water scarcity issues and improve crop yields. In addition, drip irrigation is highly efficient, providing targeted water delivery to the root zone, minimizing water losses through evaporation and runoff, and resulting in optimal crop growth. Moreover, drip irrigation systems are highly customizable, allowing farmers to tailor their strategies to meet their specific crop and soil needs. Furthermore, advancements in drip irrigation technology, such as automation and precision control, are making the systems more efficient, user-friendly, and practical, further driving their adoption in the agricultural sector.

North America has the highest share of the drip irrigation market

North America’s high level of agricultural mechanization, modernization, and government focus on sustainable agriculture and water conservation, coupled with a high level of water scarcity and drought, drive the adoption of efficient irrigation systems like drip irrigation. Moreover, the region’s significant investment and innovation in agriculture, including advanced technologies like precision agriculture and smart irrigation, further increase the adoption of drip irrigation systems. For example, in January 2022, Bayer and Netafim partnered to combat nematodes using Netafim’s precise drip irrigation technology.

 Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=drip-irrigation-market-p.php

Competitive Landscape

Jain Irrigation System Limited, Lindsay Corporation, Toro Company & Valmontare are prominent players in the global drip irrigation market.

Market Summary:

Crop Type – Report covers the Global Drip Irrigation Market by crop type from 5viewpoints

  • Field Crops
  • Vegetable corps
  • Orchard Crops
  • Vineyards
  • Other Crops

Component – Global Drip Irrigation Market, by component, break up into 5 viewpoints  

  • Emitters
  • Drip Tubes
  • Pressure Pumps
  • Valves
  • Filters
  • Others

Application- Global Drip Irrigation Market is broken up into 6 viewpoints

  • Agricultural Fields
  • Landscape and Turf Irrigation
  • Greenhouse
  • Residential
  • Others

Regions – By regions, the Global Drip Irrigation Market breaks up into 5 viewpoints

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Rest of World

Key Players- All the major players of the global drip irrigation market have been covered from 3 Viewpoints (Overview, Recent Developments, and Sales Analysis)

  • Jain Irrigation System Limited
  • Lindsay Corporation
  • The Toro Company
  • Valmont

Related Reports

Industrial Hemp Market, Global Forecast 2023-2028

Precision Irrigation Market Global Forecast 2021-2027

Global Hydroponics Market is estimated to reach US$ 19.08 Billion by 2027

Specialty Fertilizers Industry across the world is projected to grow at a CAGR of 8.10% during 2020 – 2027

Agriculture Equipment Market Size in China will grow with a CAGR of 7.75% from 2020-2026

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://linkedin.com/company/renub-research

Web: www.renub.com

Germany Toy Market on Track to Reach US$ 6.76 Billion in Revenue by 2028 | Renub Research

Germany toy market is expected to expand at a compound annual growth rate (CAGR) of 3.51% from 2022 to 2028.Germany is the fourth largest economy and a significant toy market where toys play a crucial role in social interactions, with families often bringing toys as gifts when visiting. The Germany toy industry is a significant market and one of the largest toy markets globally. The industry has a rich history of producing high-quality toys, especially handcrafted wooden toys, for centuries. German toys are known for their safety, durability, and educational value, which have made them popular with consumers worldwide. The German toy industry has seen a high percentage of e-commerce sales, which has increased due to partial lockdowns in the spring and fall.

Germany toys are known for their safety, durability, and educational value, making them popular with consumers worldwide. Handcrafted wooden toys, in particular, have a reputation for exceptional craftsmanship and unique design. This expansion of the e-commerce market has led to an increase in overall Germany toy sales. For centuries, many German towns and states have been famous for their handcrafted wooden toys, which were highly regarded worldwide. Additionally, most of the toys in Germany are made by small specialty stores, making it unique in toy sales and services, with Vedas, idee+spiel, duo, duo schreib+spiel, and others mainly serving in the wholesale role.

The rising population under 15 years of age in Germany has contributed to the growth of the toy industry in recent years. This growth in the child population has resulted in a higher demand for toys, both in traditional brick-and-mortar stores and through online channels. Moreover, the increasing number of working parents has led to a higher demand for educational and interactive toys that can help their children learn and develop while they are away at work. As a result, the toy industry in Germany has seen a surge in innovative and high-quality toy products in recent years, catering to the growing demand for safe and engaging toys for children.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/request-sample-page.php?gturl=germany-toy-market-p.php

Increasing awareness among parents about the importance of early childhood education and development is also expected to drive the growth of this segment in the coming years

The Infant/Preschool segment is expected to lead the Germany toy industry in the forecast period. This is due to the increasing demand for toys that help in the early development and education of infants and young children. According to the German Toy Industry Association, the Infant/Preschool segment accounted for the largest share of the toy market in Germany in 2022. The segment includes a wide range of toys such as plush toys, building blocks, educational toys, and ride-ons. Furthermore, the segment has seen a surge in innovative and interactive toys, such as smart toys and electronic learning toys that cater to the growing demand for educational toys.

By Segmentation: – Germany Toy Market will be broken up into 11 types

1.    Infant/Preschool

2.    Construction

3.    Doll

4.    Game Puzzles

5.    Vehicles

6.    Action Figures

7.    Outdoor Sports

8.    Plush

9.    Arts& Crafts

10.    Youth Electronics

11.    Other Toys

Specialty sales channels are expected to generate the majority of share in the Germany toy market in the upcoming years

Specialty sales channels are expected to generate the majority of revenue in the Germany toy market in the upcoming years. These specialty channels include small specialty stores, independent toy stores, and online specialty retailers that cater specifically to the toy market. According to the Renub Research, specialty sales channels accounted for less than half of the total toy sales in Germany in 2022. These channels offer a wide range of products, including exclusive and unique toys that are not available in large retail stores.

Moreover, the personalized and expert services provided by these channels attract consumers who prefer a more intimate and customized shopping experience. With the growth of e-commerce, online specialty retailers are gaining popularity among consumers who seek convenience and a wider range of products. The trend is expected to continue in the coming years as consumers increasingly prioritize personalized and unique products and services.

By Sales Channel: – Germany Toy Market will be broken up into 5 types

1.    Specialty

2.    Department Stores

3.    Discounters

4.    E-commerce

5.    Others

Key Company

Some major companies in the German toy industry are Mattel, LEGO Group, Hasbro, Ravensburger, VTech, and Spin Master Corp. They have a significant market presence in Germany, producing, marketing, and distributing toys, games, and related products. These companies compete based on factors such as innovation, product quality, pricing, and distribution strategies. The German toy industry also includes many small and medium-sized companies, particularly in the wooden and educational toy segments, that cater to niche markets with specialized products and services.

All company have been covered from 3 viewpoints

•    Overviews

•    Recent Developments

•    Revenues

Company Analysis: Germany Toy Market

1.    Mattel, Hasbro

2.    LEGO Group

3.    Ravensburger

4.    Spin Master Corp

5.    Vetch

Browse Related Report:

United States Toys Market:  https://www.renub.com/united-states-toys-market-p.php

Folding Furniture Market: https://www.renub.com/folding-furniture-market-p.php

France Toys Market: https://www.renub.com/france-toy-market-p.php

China Toys Market: https://www.renub.com/china-toys-market-game-puzzle-dolls-and-forecast-47-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: http://www.renub.com

United States Diabetes Market, Size | Growth Forecast | 2028

Renub Research has recently released a report named ” United States Diabetes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” providing a detailed industry analysis that consists of market share insights. In addition, the report covers research on competitors and areas and current advancements in the United States Diabetes Market. The United States Diabetes Market shall experience a CAGR of 3.26% by 2028. 

Diabetes is a chronic disease that influences how the body processes blood sugar. In the United States, diabetes is a prevalent health concern. According to the National Diabetes Statistics Report, 11.3% of the U.S. population, equivalent to 37.3 million individuals, have diabetes. Among them, 28.7 million people are diagnosed, including 28.5 million adults, while 8.5 million people are undiagnosed, and 23.0% of adults remain undiagnosed. Most of these are type 2 diabetes, closely linked to lifestyle factors like obesity and physical inactivity. The high generality of diabetes in the U.S. has significant health and economic consequences, including increased healthcare costs and a higher risk of complications like heart disease, kidney failure, and blindness.

Additionally, there is a growing elderly population in the United States, and diabetes is more prevalent among older adults. The Congressional Budget Office (CBO) has anticipated that, on average, 73 million people will be aged 65 or older during the period spanning from 2023 to 2053. Furthermore, advancements in diabetes treatment and management technologies, like continuous glucose monitoring systems and insulin pumps, drive the market’s growth. In addition, the increasing focus on diabetes prevention and awareness campaigns contributes to the market’s growth. Finally, government initiatives to improve diabetes care and support for research and development of diabetes treatments are also driving the growth of the United States diabetes market.

The National Diabetes Prevention Program (DPP), Medicare Diabetes Prevention Program (MDPP), National Diabetes Education Program (NDEP), American Diabetes Association (ADA), and Affordable Care Act (ACA) are government initiatives aimed at preventing or delaying the onset of type 2 diabetes, improving treatment and outcomes for people with diabetes, and expanding access to diabetes prevention, treatment, and care services. The DPP and MDPP are lifestyle change programs that prevent or delay type 2 diabetes while the NDEP seeks to improve treatment and outcomes for people with diabetes. In addition, the ADA provides information, advocacy, and support for people with diabetes, and the ACA includes provisions to improve access to diabetes prevention, treatment, and care services.

Increasing prevalence of diabetes shall drive the demand for insulin pens and CGM in the United States diabetes market

Insulin pens are preferred by patients over traditional vials and syringes as they are beneficial and offer greater accuracy in dosage. Moreover, the increasing prevalence of type 1 and type 2 diabetes in the United States has increased the demand for insulin pens. On the other hand, the CGM market is growing due to the development of advanced technology and the increasing need for continuous monitoring of glucose levels in diabetes patients.

CGMs allow patients to monitor their glucose levels in real time, giving them greater control over their diabetes management and reducing the risk of complications. Additionally, the growing awareness about the benefits of insulin pens and CGMs among healthcare professionals and patients contributes to their increasing adoption in the United States diabetes market.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-diabetes-market-p.php

Segments: United States diabetes Market based on Devices

1.    Continuous Glucose Monitoring (CGM)

2.    Self-Monitoring Blood Glucose (SMBG)

3.    Insulin Pen

4.    Insulin Pump

United States Diabetes Sub-Segment Analysis

Continuous Glucose Monitoring (CGM) – United State Food Market breakup from four viewpoints

1.    Glucose Sensor Market & Forecast

2.    CGM Transmitter Market & Forecast

3.    CGM User

4.    CGM Reimbursement

SMBG – United State Food Market breakup from five viewpoints

1.    Test Strips Market and Forecast

2.    Lancet Market and Forecast

3.    Meter Market and Forecast

4.    Blood Glucose (SMBG) Users

5.    Blood Glucose Devices Reimbursement

3. Insulin Pen Market – United State Food Market breakup from six viewpoints

1.    Disposable Insulin Pen

2.    Reusable Insulin Pen

3.    Smart Insulin Pen

4.    Insulin Pen Needle Market

5.    Insulin Pen Users

6.    Reimbursement Policies

Insulin Pump Market – United State Food Market breakup from four viewpoints

1.    Insulin Pump Market

2.    Insulin Pump Users

3.    Insulin Pump Products

4.    Reimbursement Policies

Competitive Landscape

The United States diabetes market is somewhat fragmented, with few notable brand and generic players. Some of the major companies in this market include B. Braun Melsungen AG, Eli Lilly, and Company, Terumo Corporation, Becton, Dickinson (B.D.), Novo Nordisk, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care.

Components like the growing prevalence of diabetes, the demand for advanced management technologies, multiple treatment options, and government initiatives fuel the U.S. diabetes market’s competition. With many players entering the market, companies compete to innovate and develop new products to increase their market share. In addition, the presence of established and generic players intensifies the competition further.

All the 13 Companies Studied in the United State Food Market Report have been Studied from 3 Points

•    Company Overview

•    Recent Developments

•    Financial Insight

Company Analysis

1.    B. Braun Melsungen AG

2.    Eli Lilly and Company

3.    Terumo Corporation

4.    Becton, Dickinson (B.D.)

5.    Novo Nordisk

6.    Ypsomed AG

7.    Medtronic

8.    Insulet Corporations

9.    Abbott Laboratories

10.    DarioHealth Crop

11.    Dexcom, Inc

12.    Roche Diagnostic

13.    Tandem Diabetes Care

Related Reports

Germany Diabetes Market, Size, Forecast 2023-2028

Japan Diabetes Market, Size, Forecast 2023-2028

Switzerland Diabetes Market, Size, Forecast 2023-2028

Sweden Diabetes Market, Size, Forecast 2023-2028

 About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

North America Kidney Transplant Market, Size, Share, Growth, Forecast 2023 – 2028 | Renub Research

Renub Research has recently published a report titled “North America Kidney Transplant Market: North America Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension. North America Kidney Transplant Market is projected to grow with a CAGR of 5.38% over the forecast period (2023-2027).

The North America kidney transplant industry is a dynamic and rapidly evolving sector within the healthcare landscape. With advancements in medical technology, surgical techniques, and immunosuppressive therapies, kidney transplantation has become an established and successful treatment option for end-stage renal disease (ESRD) patients. North America, comprising the United States and Canada, has emerged as a prominent region in the field of kidney transplantation, with a robust infrastructure, well-equipped transplant centers, and a large pool of skilled healthcare professionals. The region also benefits from extensive research and development activities, fostering innovation and improving patient outcomes.

Request a free sample copy of the report:  https://www.renub.com/request-sample-page.php?gturl=kidney-transplant-market-numbers-and-forecast-for-united-states-mexico-and-canada-302-p.php

Additionally, favorable reimbursement policies, government initiatives, and increased awareness about organ donation have contributed to the growth of the North America kidney transplant industry. As a result, the industry is expected to witness continued growth and advancements in the coming years, providing renewed hope and improved quality of life for ESRD patients.           

In 2022, the United States kidney transplant industry achieved a remarkable milestone with over 25,000 life-saving kidney transplants performed, setting a new record in the region. However, the demand for kidney transplantation continues to outpace the supply of available organs. As of May 2023, the United States alone has 88,753 individuals on the waiting list for a kidney transplant, according to the United Network for Organ Sharing (UNOS). This staggering number highlights the urgent need for increasing organ donations and improving transplant processes. Efforts are underway to raise awareness about organ donation, enhance organ procurement and allocation systems, and promote research and development in the field of kidney transplantation. By addressing these challenges and expanding access to transplantation, the North America kidney transplant industry aims to save more lives and improve the quality of life for patients suffering from end-stage renal disease.

United States has positioned itself as the frontrunner in the kidney transplant industry, leading the market with the highest market share

Renowned for its well-developed healthcare system, advanced medical facilities, and robust infrastructure, the country has become a preferred destination for individuals seeking kidney transplantation. With top-tier transplant centres and highly skilled healthcare professionals specializing in successful kidney transplant procedures, the United States offers exceptional expertise in the field.

Moreover, the country’s continuous progress in immunosuppressive therapies, surgical techniques, and organ procurement processes has further solidified its dominant market position. The substantial market share of the United States in the kidney transplant industry demonstrates its unwavering commitment to delivering quality healthcare services and driving improved outcomes for patients with end-stage renal disease.

Region – Kidney Transplant Market breakup from 3 Regions:

1.    United States

2.    Canada

3.    Mexico

Living Donor Transplant market is on track to witness significant growth in the foreseeable future

Living donor transplantation offers numerous advantages, including superior outcomes, reduced waiting times, and improved graft survival rates when compared to deceased donor transplantation. These compelling benefits, coupled with the increasing awareness and acceptance of living donor transplantation, are serving as key drivers for market expansion. Furthermore, continuous advancements in surgical techniques, immunosuppressive therapies, and organ preservation methods have substantially enhanced the success rates of living donor transplants, further augmenting the market’s growth trajectory. The rising demand for organs, coupled with the persistent shortage of deceased donor organs, has underscored the importance of living donor transplantation as a viable solution. Consequently, the Living Donor Transplant market is projected to experience remarkable growth in the coming years, bringing immense benefits to patients in the need of organ transplantation and contributing to the advancement of the broader healthcare industry.

Type – Kidney Transplant Market breakup from 2 viewpoints:

1.    Deceased Donor Transplant

2.    Living Donor Transplant

Calcineurin inhibitors are a vital class of immunosuppressive drugs widely employed in North America kidney transplant market

The Calcineurin Inhibitors market is experiencing significant growth driven by advancements in technology and healthcare. These inhibitors play a crucial role in immunosuppressive therapy for organ transplantation and autoimmune disorders. Research and development efforts have led to improved formulation, delivery, and effectiveness of these inhibitors. Innovations in drug delivery systems and bioavailability have increased demand. Factors such as the rising rates of organ transplantation, incidence of autoimmune diseases, and aging population contribute to market growth. The integration of digital healthcare solutions like telemedicine and remote monitoring has further accelerated the adoption of calcineurin inhibitors.

Drugs – Kidney Transplant Market breakup from 4 viewpoints

1.    Calcineurin inhibitors

2.    Antiproliferative agents

3.    mTor inhibitor

4.    Steroids

5.    Antibodies

Browse Related Report:

Electric Wheelchair Market: https://www.renub.com/electric-wheelchair-market-p.php

Oncology Precision Medicine Market: https://www.renub.com/oncology-precision-medicine-market-p.php

Ultrasound Device Market: https://www.renub.com/ultrasound-device-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com